Olivia Roger

Takeda is teaming up with nference to identify personalised treatment approaches for patients with inflammatory bowel disease (IBD). The strategic

GE HealthCare snaps up Intelligent Ultrasound's clinical AI business

Headway rakes in $100M, boosting valuation to $2.3B Mental health startup Headway has more than doubled its valuation to $2.3 billion after raising $100 million in a series D financing.

Guardant's colon cancer blood test scores US nod for average-risk adults

AI bowel cancer test could help patients avoid chemotherapy: study

Surging payor revenue drives Talkspace's Q2 sales as loss improves

Medtronic's scores FDA nod for asleep deep brain stimulation The FDA has cleared Medtronic's deep brain stimulation (DBS) technology for

Siemens Healthineers has agreed to acquire the radiodiagnostic arm of Advanced Accelerator Applications (AAA) from Novartis for over €200 million ($223 million), according to the Financial Times.

Biochip-based diagnostic could detect brain cancer with a blood sample

Friday Five: Illumina claims a victory; Abbott rolls out Lingo; Click's DTx curbs migraine; and more EU's top court rules in favour of Illumina in Grail deal dispute